Fact CheckerSign in

NCT07617636Not yet recruiting

Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial Intelligence

Artificial Intelligence for the Analysis of STAS and Lung Cancer Risk Stratification

Source: ClinicalTrials.gov · Last updated 23 Oct 2026

Brief summary (registry, in English)

Observational cohort study involving individuals of both sexes with a history of smoking, residing in municipalities in the state of Bahia and attended by the mobile unit, with the aim of evaluating the integration of artificial intelligence (AI) in the detection of pulmonary nodules and the prediction of ASCT in high-risk individuals undergoing CT screening.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
1500 (estimated)
First submitted
25 May 2026
Start date
30 Dec 2026
Primary completion date
31 Aug 2027
Lead sponsor
AstraZeneca
Diseases
Lung cancer
NCT number
NCT07617636

What you commit to

  • Study type: Observational
  • Planned participants: 1500
  • From 30 Dec 2026 to the primary completion date, 31 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals who are unable to undergo a CT scan;
    • Individuals who cannot tolerate lying on their back for more than 10 minutes continuously;
    • Individuals who present with symptoms highly suggestive of lung cancer (hemoptysis, chest pain, altered cough pattern, unintentional weight loss greater than 10 kg);
    • Diagnosis of severe heart disease while using multiple medications;
    • Diagnosis of severe lung disease, using multiple medications and/or requiring home oxygen therapy;
    • History of radiation therapy to the chest area;
    • Individuals undergoing cancer evaluation or treatment;
    • Individuals exhibiting signs of respiratory distress (nasal flaring, suprasternal retraction, use of accessory muscles, cyanosis);
    • Pregnancy.

Who the study is looking for

  • Individuals of both sexes, smokers or former smokers for a maximum of 15 years;
    • Smoking history of 20 pack-years or more;
    • Between 50 and 80 years old;
    • Provision of Free and Informed Consent in writing, signed and dated.

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.